Precision health depends on access to high-quality, research-ready data — yet fragmented systems, regulatory complexity, and limited imaging availability continue to slow progress. For pharma and biotech teams developing diagnostics and therapeutics, the gap between having data and being able to act on it remains a fundamental barrier. This session focuses on the infrastructure and partnerships that close that gap. By exploring how Verily's AI-native platform and Segmed's imaging assets work together, Denise demonstrates how an integrated ecosystem can support governed, scalable workflows, from dataset discovery to secure analysis, enabling teams to move faster from insight to impact. Whether you're developing AI models, running clinical trials, or evaluating data partnerships, this session offers a practical roadmap for accelerating precision health with real-world imaging data.
#AIinRadiology #RWID #MedicalImagingData #AIinHealthcare #MultimodalDatasets #BytesofInnovation
Comments